Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical Trials
2004 ◽
Vol 3
(3)
◽
pp. 92-98
◽
Keyword(s):
Keyword(s):
1997 ◽
Vol 20
(2)
◽
pp. 175-180
◽
1999 ◽
Vol 72
(5)
◽
pp. 1093-1100
◽
Keyword(s):
1996 ◽
Vol 2
(3)
◽
pp. 307-315
◽
Keyword(s):
1997 ◽
Vol 14
(4)
◽
pp. 421-428
◽
Keyword(s):
1994 ◽
Vol 116
(26)
◽
pp. 12113-12114
◽
Keyword(s):